Literature DB >> 14402142

Visual disturbances with antimalarial drugs, with particular reference to chloroquine keratopathy.

H E HOBBS, C D CALNAN.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/toxicology; CHLOROQUINE/toxicology; EYE/pharmacology

Mesh：

Substances：

Year:  1959        PMID： 14402142     DOI： 10.1001/archderm.1959.01560230043008

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  8 in total

1.  Ocular complications induced by chloroquine therapy.

Authors:  S GOLDEN; N VAN DONGE
Journal:  Calif Med       Date:  1963-06

2.  Synthetic antimalarial drug therapy in lupus erythematosus and polymorphous light eruptions.

Authors:  J H EPSTEIN
Journal:  Calif Med       Date:  1960-02

3.  Ocular Complications of Treatment with Chloroquine and Related Antimalarial Drugs.

Authors: 
Journal:  Can Med Assoc J       Date:  1963-03-09       Impact factor: 8.262

4.  Study of chloroquine toxicity and a drug-induced cerebrospinal lipodystrophy in swine.

Authors:  C A Gleiser; W W Bay; T W Dukes; R S Brown; W K Read; K R Pierce
Journal:  Am J Pathol       Date:  1968-07       Impact factor: 4.307

5.  Electro-oculogram findings in patients treated with antimalarial drugs.

Authors:  H Kolb
Journal:  Br J Ophthalmol       Date:  1965-11       Impact factor: 4.638

6.  Electro-oculograms in the early diagnosis of chloroquine retinopathy.

Authors:  M S Weinreb
Journal:  Calif Med       Date:  1967-03

7.  OCULAR COMPLICATIONS OF CHLOROQUINE THERAPY.

Authors:  E TAMLER
Journal:  Calif Med       Date:  1965-07

8.  Alterations in Corneal Sensory Nerves During Homeostasis, Aging, and After Injury in Mice Lacking the Heparan Sulfate Proteoglycan Syndecan-1.

Authors:  Sonali Pal-Ghosh; Gauri Tadvalkar; Mary Ann Stepp
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.